A randomized controlled clinical trial on irinotecan/cisplatin versus gemcitabine/cisplatin as the first-line treatment in advanced non-small cell lung cancer / 中国癌症杂志
China Oncology
; (12)2006.
Article
在 Zh
| WPRIM
| ID: wpr-545488
Responsible library:
WPRO
ABSTRACT
0.05).The incidence rate of diarrhea in IP group was 48.4% it was significantly higher than GP group(P